clinical trial · NCT07254208
A Long-term Observational Study in Participants Who Have Received PBGENE-HBV
Precision BioSciences, Inc.·—·enrolling by invitation·n = 45
Chronic HBV InfectionPBGENE-HBV
brief summary
Participants who received at least one dose of PBGENE-HBV will be enrolled in this LTFU study.
started
Dec 25, 2025
primary completion
Jan 1, 2040
completion
Jun 1, 2040
last updated
Apr 22, 2026
detailed description
This is a LTFU observational study designed to evaluate the safety of PBGENE-HBV in participants previously exposed to PBGENE-HBV. This study protocol does not include administration of PBGENE-HBV.
official title
A Long-term Observational Study in Participants Who Have Received PBGENE-HBV, an In Vivo Gene Editing Investigational Product, in a Prior Clinical Study
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol